• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2022 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • SOP Web STAT
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments
« Antimicrobial resistance
The multi-step transfer of phosphate bond and hydrogen exchange energy »

2nd Annual EAST COAST-WEST COAST CRO/CMO US Summit, October 23, 2014 3:30 PM – 8:00 PM, San Diego Marriott La Jolla

August 18, 2014 by 2012pharmaceutical

2nd Annual EAST COAST-WEST COAST CRO/CMO US Summit

Bridging the World’s Most Robust R&D Ecosystems & Meeting Their Leaders

  

Organizers:

  • BVS
  • SHELLEYCO

 

ABOUT THE SUMMIT

The 2nd Annual EAST COAST-WEST COAST   CRO/CMO US Summit is a unique program developed to build a bridge between the world’s three largest life science clusters: San Francisco, Boston, and San Diego.   This program aims to develop and foster relationships between the communities, and allow for a discussion of the important issues facing our industry.

This event is ideal for scientists, sourcing specialists, and entrepreneurs throughout all stages in the development of a commercialized drug. Attendees will network with and learn from researchers from both the sponsor and provider companies about successful ways to accelerate drug development.

 

WHY SHOULD YOU ATTEND?

 

MASTER integrating internal and external resources for smooth tech transfer between teams

 

EVALUATE how dedicated specialists enable flexible and rapid project prioritization

 

LEARN from industry leaders what works, what doesn’t when working with CRO/CMOs

 

DISCOVER how specialized service partners can help your program keep to timeline

 

 

AGENDA

 

3:30 PM Registration & Networking in Exhibit Area

 

4:00 PM Speed Dating—A Rapid Approach for Initial

Partnering Discussions

 

5:00 PM Welcome Remarks

Opening Presentation by Pharmorphix

Case Studies by Toxikon & Charles River Labs and two of their clients.

Industry & Expert Panel Discussions:

  • Biotech Executives Orchestrating External

Distributed Resources

  • US CROs are Working Together to Provide a More

Integrated Resource

  • VCs will discuss the Value of Local vs.

International CRO/CMOs

 

6:30 PM Dinner, Dessert & Networking in Exhibit Area

 

Speakers Include:

  • Pam Gardner, President & CEO, BVS
  • Shelley Amster, Founder & Principal, ShelleyCO
  • BIOCOM CRO CMO Group Representatives
  • Chris Worrall PhD, Pharmorphix®, a Division of Sigma-Aldrich
  • Laxman Desai, President & CEO, Toxikon
  • Stephanie Shi, PhD, Integrated Sourcing Lead, Pfizer
  • J. David Enloe Jr., President & CEO, Ajinomoto Althea In
  • Tracy (Lawhon) Parrott, Chief Development Officer, Tragara Pharmaceuticals
  • EVENT SPONSORS

 

CLICK HERE & REGISTER TODAY!

Thursday, October 23, 2014

3:30 PM – 8:00 PM

 

San Diego Marriott La Jolla

4240 La Jolla Village Drive, La Jolla, CA 92037

 

 

ATTENDANCE FEES:

Attendee Fee: $50.00

Service Providers Not Exhibiting: $100.00

EXHIBITOR FEE: $850

Sponsorships still available

Contact pam.gardner@bvsweb.com for further details

 

+50 EXHIBITORS

http://www.bvsweb.com/php/index.php

 

 

 

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to print (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Like this:

Like Loading...

Posted in Conference Coverage with Social Media |

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 1,977 other subscribers

  • Recent Posts

    • Sperm epigenetic clock and pregnancy outcomes May 14, 2022
    • Lessons on the Frontier of Gene & Cell Therapy – The Disruptive Dozen 12 #GCT Breakthroughs that are revolutionizing Healthcare May 9, 2022
    • Relevance of Twitter.com forthcoming Payment System for Scientific Content Promotion and Monetization May 9, 2022
    • Tweets at #WMIF2022 by @pharma_BI & @AVIVA1950 and all Retweets of these Tweets – 2022 World Medical Innovation Forum, GENE & CELL THERAPY • MAY 2–4, 2022 • BOSTON May 7, 2022
    • Data Science: Step by Step – A Resource for LPBI Group’s One-Year Internship in IT, IS, DS May 7, 2022
    • 2022 World Medical Innovation Forum, GENE & CELL THERAPY • MAY 2–4, 2022 • BOSTON • IN-PERSON May 1, 2022
    • We Celebrate TEN Years of Excellence, LPBI Group: 4/2012 – 4/2022 April 25, 2022
    • The durability of T cells versus the triggered of high levels of antibodies: Rationale for the development of T cells focused vaccines   April 22, 2022
    • The Framingham Study: Across 6 Decades, Cardiovascular Disease Among Middle-Aged Adults – mean life expectancy increased and the RLR of ASCVD decreased. Effective primary prevention efforts and better screening increased. April 22, 2022
    • TricValve Transcatheter Bicaval Valves System – Interventional cardiologists at Cleveland Clinic have successfully completed the first implantation in North America April 20, 2022
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 Amandeep Kaur
    • 1 Aashir Awan, Phd
    • 1 Abhisar Anand
    • 1 Adina Hazan
    • 1 Alan F. Kaul, PharmD., MS, MBA, FCCP
    • 1 alexcrystal6
    • 1 anamikasarkar
    • 1 apreconasia
    • 1 aviralvatsa
    • 1 David Orchard-Webb, PhD
    • 1 danutdaagmailcom
    • 1 Demet Sag, Ph.D., CRA, GCP
    • 1 Dror Nir
    • 1 dsmolyar
    • 1 Ethan Coomber
    • 1 evelinacohn
    • 1 Gail S Thornton
    • 1 Irina Robu
    • 1 jayzmit48
    • 1 jdpmd
    • 1 jshertok
    • 1 kellyperlman
    • 1 Ed Kislauskis
    • 1 larryhbern
    • 1 Madison Davis
    • 1 marzankhan
    • 1 megbaker58
    • 1 ofermar2020
    • 1 Dr. Pati
    • 1 pkandala
    • 1 Rosalind Codrington, PhD
    • 1 ritusaxena
    • 1 Rick Mandahl
    • 1 sjwilliamspa
    • 1 Srinivas Sriram
    • 1 stuartlpbi
    • 1 Dr. Sudipta Saha
    • 1 tildabarliya
    • 1 vaishnavee24
    • 1 zraviv06
    • 1 zs22

Powered by WordPress.com.

WPThemes.


loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: